Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil

International Journal of STD and AIDS

Volumn 23, Issue 1, 2012, Pages 44-47

  Joao, E C ^a   Gouvea M I ^a,b   Menezes, J A ^a   Sidi, L C ^a   Cruz, M L S ^a   Berardo, P T ^a   Ceci, L ^a   Cardoso, C A ^a   Teixeira, M L B ^b   Calvet, G A ^b   Matos, H J ^c  

^a HOSPITAL DOS SERVIDORES DO ESTADO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brazil; HAART; HIV; Mother to child transmission; PMTCT; Prevention; Viral load; Women

Indexed keywords

NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; DELIVERY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MOTHER TO CHILD TRANSMISSION; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVALS; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; TIME FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84857476032     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010545     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Achievements in public health. Reduction in perinatal transmission of HIV infection - United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006;55:592-597
2. Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG 2008;115:1078-86
3. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-65
4. Townsend CL, Cortina-Borja M, Peckham CS, et al. Low rates of motherto- child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008;22:973-81
5. Ministério da Saúde, Secretaria de Vigilncia em Saúde, Departamento de DST. Aids e Hepatites Virais. Recomendacões para Profilaxia da Transmissaõ Vertical do HIV e Terapia Antirretroviral em Gestantes - 2010. See http://www.aids.gov.br/sites/default/files/consenso_gestantes_2010_vf.pdf (last accessed 2 December 2010)
6. Panel on Treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010;1-117. See http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf (last accessed 2 December 2010)
7. Tubiana R, Le Chenadec J, Rouzioux C, et al. Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load 500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis 2010;50:585-596
8. Ioannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads, 1000 copies/ml,1000 copies/ml. J Infect Dis 2001;183:539-45
9. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS 2008;22:289-99
10. Statistical Package for the Social Sciences (SPSS) for Windows [computer software]. Version 13.0. Chicago: SPSS Inc, 2004
11. Marazzi MC, Liotta G, Nielsen-Saines K, et al. Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life. AIDS 2010;24:2819-25
12. Patel D, Cortina-Borja M, Thorne C, Newell ML. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis 2007;44:1647-56
13. Phillips AN, Staszewski S, Weber R, et al. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA 2001;286:2560-67
14. Katz IT, Shapiro R, Li D, et al. Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study. J Acquir Immune Defic Syndr 2010;54:27-34